[go: up one dir, main page]

MX2012013835A - Cepas probioticas para aumentar la resistencia transepitelial. - Google Patents

Cepas probioticas para aumentar la resistencia transepitelial.

Info

Publication number
MX2012013835A
MX2012013835A MX2012013835A MX2012013835A MX2012013835A MX 2012013835 A MX2012013835 A MX 2012013835A MX 2012013835 A MX2012013835 A MX 2012013835A MX 2012013835 A MX2012013835 A MX 2012013835A MX 2012013835 A MX2012013835 A MX 2012013835A
Authority
MX
Mexico
Prior art keywords
transepithelial resistance
probiotic strains
improving
improving transepithelial
resistance
Prior art date
Application number
MX2012013835A
Other languages
English (en)
Other versions
MX346332B (es
Inventor
Isabelle Chambaud
Gianfranco Grompone
Sophie Legrain-Raspaud
Sandrine Capronnier
Biliana Lesic
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Publication of MX2012013835A publication Critical patent/MX2012013835A/es
Publication of MX346332B publication Critical patent/MX346332B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La invención se refiere al uso de bacterias de ácido láctico para aumentar la resistencia transepitelial y más particularmente para tratar y/o prevenir los problemas intestinales tales como constipación y/o enfermedad del intestino irritable.
MX2012013835A 2010-05-28 2011-05-30 Cepas probioticas para aumentar la resistencia transepitelial. MX346332B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2010/001536 WO2011148220A1 (en) 2010-05-28 2010-05-28 Probiotic strains for use in improving transepithelial resistance
PCT/IB2011/052368 WO2011148358A1 (en) 2010-05-28 2011-05-30 Probiotic strains for use in improving transepithelial resistance

Publications (2)

Publication Number Publication Date
MX2012013835A true MX2012013835A (es) 2013-04-08
MX346332B MX346332B (es) 2017-03-15

Family

ID=43334416

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012013835A MX346332B (es) 2010-05-28 2011-05-30 Cepas probioticas para aumentar la resistencia transepitelial.

Country Status (13)

Country Link
US (1) US9402872B2 (es)
EP (1) EP2575834B1 (es)
JP (1) JP5816273B2 (es)
KR (1) KR101790683B1 (es)
CN (1) CN103079581B (es)
CA (1) CA2800770C (es)
EA (1) EA024443B1 (es)
ES (1) ES2514326T3 (es)
MX (1) MX346332B (es)
PL (1) PL2575834T3 (es)
PT (1) PT2575834E (es)
WO (2) WO2011148220A1 (es)
ZA (1) ZA201208978B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011148219A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
BR112014015527B1 (pt) * 2011-12-21 2021-06-22 Compagnie Gervais Danone Composição, método para obtenção de uma composição e uso da composição
WO2014096901A1 (en) * 2012-12-18 2014-06-26 Compagnie Gervais Danone Strain of bifidobacterium animalis ssp. animalis
KR20180027506A (ko) * 2015-07-10 2018-03-14 디에스엠 아이피 어셋츠 비.브이. 염증 질병의 예방 및 치료를 위한 식품 및/또는 사료 조성물
WO2023118510A1 (en) 2021-12-22 2023-06-29 N.V. Nutricia Mix of specific bifidobacterium species and specific non-digestible oligosaccharides
WO2025003346A1 (en) 2023-06-28 2025-01-02 N.V. Nutricia Nutritional composition comprising urea, non-digestible oligosaccharide, and bifidobacteria
WO2025229071A1 (en) 2024-04-30 2025-11-06 N.V. Nutricia Synbiotic combination
WO2025229097A1 (en) 2024-04-30 2025-11-06 N.V. Nutricia Synbiotic mixture for young children
WO2025229094A1 (en) 2024-04-30 2025-11-06 N.V. Nutricia Mixture of non-digestible saccharides stimulates gut barier

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1119154C (zh) * 1998-01-20 2003-08-27 上海信谊药业有限公司 双歧三联活菌制剂及制备方法
US20030092163A1 (en) 2001-07-26 2003-05-15 Collins John Kevin Probiotic bifidobacterium strains
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US7959912B2 (en) * 2005-05-16 2011-06-14 Universite De Liege Probiotic bifidobacterial species
SI1931363T1 (sl) 2005-09-28 2016-02-29 Nordisk Rebalance A/S Zdravljenje vnetnih črevesnih bolezni z uporabo probiotičnih bakterij in fermentiranega žita kot efektorjev zdravljenja
CN101410128A (zh) * 2006-01-27 2009-04-15 丹尼斯科公司 益生微生物用于治疗和预防肥胖及相关病症的用途
ES2395838T3 (es) 2007-12-21 2013-02-15 Compagnie Gervais Danone Método para disminuir el contorno abdominal administrando una bacteria del tipo Bifidobacterium
WO2009158384A1 (en) * 2008-06-27 2009-12-30 The Procter & Gamble Company Methods and kits for the treatment inhibition, and maintenance of gastrointestinal disorders

Also Published As

Publication number Publication date
PL2575834T3 (pl) 2015-03-31
EA201291440A1 (ru) 2013-04-30
JP5816273B2 (ja) 2015-11-18
EP2575834B1 (en) 2014-06-25
CA2800770C (en) 2019-09-10
BR112012030363A2 (pt) 2016-08-09
US20130216510A1 (en) 2013-08-22
ES2514326T3 (es) 2014-10-28
KR101790683B1 (ko) 2017-10-26
CN103079581B (zh) 2015-08-05
ZA201208978B (en) 2014-04-30
KR20130141350A (ko) 2013-12-26
PT2575834E (pt) 2014-10-01
CA2800770A1 (en) 2011-12-01
MX346332B (es) 2017-03-15
EA024443B1 (ru) 2016-09-30
JP2013527194A (ja) 2013-06-27
EP2575834A1 (en) 2013-04-10
WO2011148358A1 (en) 2011-12-01
US9402872B2 (en) 2016-08-02
CN103079581A (zh) 2013-05-01
WO2011148220A1 (en) 2011-12-01

Similar Documents

Publication Publication Date Title
MX345063B (es) Cepas probióticas para mejorar el sistema nervioso entérico.
MX2012013835A (es) Cepas probioticas para aumentar la resistencia transepitelial.
IN2012DN01638A (es)
IN2012DN02463A (es)
GB2480042A (en) Prebiotic formulations and methods of use
IN2012DN02737A (es)
UA108198C2 (uk) Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування
BR112012033212A2 (pt) uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica
MX2011005527A (es) Uso de la bacteria de acido lactico para tratar o prevenir el eczema.
WO2012112777A3 (en) Biosynthesis of human milk oligosaccharides in engineered bacteria
GB2482536B (en) Expression of antibody or a fragment thereof in lactobacillus
PH12012501257A1 (en) Capsule for the preparation of a beverage comprising an identification code
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
WO2011110918A8 (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
MX2017014787A (es) Poblaciones bacterianas para promover la salud.
MX2015006491A (es) Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas.
GB2511993A (en) Prebiotic formulations and methods of use
PL2753687T3 (pl) Szczepy bakterii kwasu mlekowego i/lub bifidobakterii hamujących/zmniejszających wzrost różnych biotypów E. coli i różnych biotypów bakterii z rodzaju Clostridium
IN2012DN00624A (es)
MX2011008398A (es) Lactobacillus helveticus cncm i-4095 y el control del peso.
GEP201606589B (en) Novel bacterium and extracts of said bacterium and the use of same in dermatology
MY158310A (en) Prevention and treatment of allergic diarrhoea
MX2011008400A (es) Lactobacillus rhamnosus cncm i-4096 y el control del peso.
IN2012DN06392A (es)
EP2538970A4 (en) TREATMENT OR PREVENTION OF INFECTION

Legal Events

Date Code Title Description
FG Grant or registration